Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs FITB✓SelectedUSD · FITBMRNA vs FITB performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs FITB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+958.0%
FITB return
+171.8%
Excess return
+786.2%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioFITBExcessAlpha
1D-4.8%-0.6%-4.3%-4.8%
7D-20.9%-4.5%-16.4%-20.5%
30D-13.3%+2.9%-16.2%-13.4%
3M+212.6%-8.5%+221.1%+214.6%
6M+309.0%+10.1%+299.0%+299.7%
YTD+567.3%+13.8%+553.6%+548.1%
1Y+689.7%+29.9%+659.8%+652.6%
3Y+157.4%+109.9%+47.6%+135.1%
5Y-21.7%+42.2%-63.9%-28.4%
All+958.0%+171.8%+786.2%+1,041.0%

Cumulative growth

Daily Returns

Daily percentage return beside FITB.

Daily Out/Under-Performance

Portfolio return minus FITB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FITB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded FITB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling